Scarica l'app Stockscreener
3.00
1.15%
-0.035
Dopo l'orario di chiusura:
3.00
Precedente Chiudi:
$3.035
Aprire:
$3.14
Volume 24 ore:
37,893
Relative Volume:
0.67
Capitalizzazione di mercato:
$34.36M
Reddito:
-
Utile/perdita netta:
$-11.61M
Rapporto P/E:
-2.3173
EPS:
-1.2946
Flusso di cassa netto:
$-11.82M
1 W Prestazione:
+19.76%
1M Prestazione:
+50.00%
6M Prestazione:
-1.32%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.9045
$3.14
Intervallo di 1 settimana:
$2.37
$3.14
Portata 52W:
$1.75
$4.965
Grace Therapeutics Inc Stock (GRCE) Company Profile
Nome
Grace Therapeutics Inc
Settore
Industria
Telefono
609-322-1602
Indirizzo
103 CARNEGIE CENTER, PRINCETON
Confronta GRCE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.00 | 34.36M | 0 | -11.61M | -11.82M | -1.2946 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-02 | Iniziato | TD Cowen | Buy |
| 2020-09-01 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-06 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | Iniziato | B. Riley FBR | Buy |
| 2019-07-18 | Iniziato | Oppenheimer | Outperform |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Grace Therapeutics Inc Borsa (GRCE) Ultime notizie
Grace Therapeutics (NASDAQ:GRCE) Research Coverage Started at TD Cowen - Defense World
TD Cowen starts Grace Therapeutics stock with Buy, $12 target By Investing.com - Investing.com Canada
Biotech Stock Ends Week On High Note Following Bullish Coverage Initiation - The Globe and Mail
TD Cowen Initiates Coverage on Grace Therapeutics With Buy Rating, $12 Price Target - marketscreener.com
Grace Therapeutics (GRCE) Receives Positive Buy Rating with Prom - GuruFocus
Grace Therapeutics (GRCE) Receives Positive Buy Rating with Promising Outlook | GRCE Stock News - GuruFocus
Moderna, Inc. - Britannica
United Rentals, Inc [URI] Records 200-Day SMA of $730.81 - knoxdaily.com
Kham's House From Grief to Grace: One Mother’s Mission to Support Young Cancer Warriors Now Celebrates Three Years of Hope - Yahoo Finance
XORTX Faces Nasdaq Price Compliance Challenge: 180 Days to Avoid Delisting Risk - Stock Titan
Grace Kao Promoted to CMO of Snap - Yahoo Finance
CoreWeave Launches NVIDIA GB200 Grace Blackwell Systems at Scale - Yahoo Finance
"Exquisite Moments of Sorrow and Grace" Debuts for National Public Health Week - Yahoo Finance
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma - BioSpace
Craig-Hallum Sticks to Its Buy Rating for Grace Therapeutics (GRCE) - The Globe and Mail
Grace Therapeutics aligns with FDA on GTx-104 NDA submission By Investing.com - Investing.com Canada
Grace Therapeutics aligns with FDA on GTx-104 NDA submission - Investing.com Australia
Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104 - The Manila Times
Grace Therapeutics Announces Alignment With The FDA Supporting The Submission For Gtx-104 - marketscreener.com
Yibin Grace launches first Next Gen textile dissolving pulp mill in China - Yahoo
Huron’s Zach Brody and Grace Schlecte Named Rising Stars and Firm Celebrates Two Recognitions - Yahoo Finance
GOLD SPONSORAvanza Capital Holdings Supports The GRACE Foundation - Yahoo Finance
Acasti Pharma stock plunges to 52-week low at $2.02 - Investing.com
Acasti Pharma stock plunges to 52-week low at $2.02 By Investing.com - Investing.com UK
Aneurysmal Subarachnoid Hemorrhage Market to Reach New Heights - openPR.com
Aneurysmal Subarachnoid Hemorrhage Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Acasti Pharma Inc., BIT Pharma, Aaron Cook, Haaglanden Medical Centre - Barchart.com
Corcept Therapeutics (NasdaqCM:CORT) Reports Positive Phase 3 Results Despite 8% Share Price Dip - Yahoo Finance
February’s phase III wins include Qyuns’ ankylosing spondylitis data - BioWorld MedTech
buildOn's Better Together Concert Returns to San Francisco with Blues Phenom Grace Bowers & The Hodge Podge - Yahoo Finance
Grace Therapeutics secures up to $30 million financing - MSN
AirNet Granted Additional 180-Day Grace Period to Regain Compliance with Nasdaq Bid Price Requirement - The Manila Times
ASUS Introduces Ascent GX10 AI Supercomputer Powered by NVIDIA GB10 Grace Blackwell Superchip - Yahoo Finance
Cadence Accelerates AI-Driven Engineering Design and Science with NVIDIA Grace Blackwell - Yahoo Finance
Synopsys Accelerates Chip Design with NVIDIA Grace Blackwell and AI to Speed Electronic Design Automation - Yahoo Finance
Subarachnoid Hemorrhage Treatment Market Size in the 7MM - openPR
Acasti Pharma stock hits 52-week low at $2.12 amid challenges - Investing.com Australia
Acasti Pharma stock hits 52-week low at $2.12 amid challenges By Investing.com - Investing.com South Africa
Tesla’s fall from grace may have no equal, says JPMorgan: ‘We struggle to think of anything analogous’ - Yahoo Finance
The Inner Circle acknowledges, Grace Merrell Slezak as a Pinnacle Professional Member Inner Circle of Excellence - Yahoo Finance
Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem - Yahoo Finance
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
Grace Therapeutics Reports Q3 Progress and Financial Results - TipRanks
Grace Therapeutics Files Form S-3 for Flexible Securities Offering - TipRanks
Grace Therapeutics to offer up to 8.8 mln shares by selling stockholders, SEC Filing shows - Marketscreener.com
FDA decision on relacorilant for Cushing’s expected by year’s end - Cushing's Disease News
CORTCorcept Therapeutics Inc Latest Stock News & Market Updates - StockTitan
New Biotech Stocks at Investorideas.com - Investorideas.com newswire
CORCEPT THERAPEUTICS INC SEC 10-K Report - TradingView
Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - The Manila Times
Grace Therapeutics Inc Azioni (GRCE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
3.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):